Af­ter re­vamp­ing R&D in a glob­al shake­up, Bay­er prep­ping new labs for an ex­pan­sion in can­cer re­search at MIT

At Bay­er, Pitts­burgh is out, Cam­bridge, MA is in.

As part of a glob­al shake­up that is cost­ing 12,000 jobs, Bay­er re­cent­ly an­nounced that it will shut down its old US HQ in Penn­syl­va­nia, ax­ing hun­dreds of staffers. And that is hap­pen­ing while R&D is tak­ing a big hit at the Ger­man multi­na­tion­al, with 900 re­searchers get­ting cut as Bay­er com­pletes the trou­ble­some Mon­san­to ac­qui­si­tion.

But that doesn’t mean they’ve stopped adding re­search staff in the fields where they plan to grow.

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER